FIASP Pen 100 IU Novo Nordisk
€219.00
Description
Brief introduction to FIASP Pen 100 IU Novo Nordisk, what it offers
FIASP Pen 100 IU by Novo Nordisk is a notable rapid-acting insulin formulation that delivers effective management of blood glucose levels, making it a popular choice for individuals with diabetes. This innovative device is designed for convenience, allowing users to administer insulin via a pre-filled pen. With the ability to start working within minutes, FIASP Pen offers a quick solution for those needing to manage their blood glucose, particularly before meals. This insulin formulation not only helps in controlling diabetes but is also garnering attention in the realm of sports pharmacology, where precise blood sugar regulation can impact overall athletic performance.
Physiological influence, results on performance
The primary physiological influence of FIASP is the rapid reduction of blood glucose levels. This can prove beneficial for athletes, especially those engaged in intensive training or competitive sports. Quick and reliable glucose management enables athletes to maintain energy levels and prolong endurance during performance. The formula is characterized by its fast absorption properties, which allow for flexibility in timing insulin doses relative to meals and physical activity. This feature can enable athletes to optimize their performance by ensuring that their body has access to necessary energy sources when needed most. Moreover, studies suggest that maintaining stable blood glucose levels can enhance cognitive functions during sports, contributing to sharper focus and improved decision-making on the field.
Side effects, safety monitoring
Despite its advantages, like any pharmacological agent, FIASP Pen is not without risks. Common side effects may include hypoglycemia, which is a concern that athletes should monitor closely. Symptoms of hypoglycemia can range from mild shakiness to severe consequences if not managed promptly. Other potential side effects can include injection site reactions, such as redness or swelling. Athletes using FIASP should engage in regular safety monitoring, checking blood glucose levels frequently to ensure they remain within a therapeutic range. Regular consultations with healthcare professionals can help tailor insulin regimens to individual sports and nutrition plans, minimizing risks while maximizing performance benefits.
How to buy FIASP Pen 100 IU Novo Nordisk, convenience and guarantees
Purchasing FIASP Pen 100 IU is a straightforward process but requires a prescription from a licensed healthcare provider. Athletes looking to integrate this insulin formulation into their regimen should first consult with a medical professional to evaluate its suitability for their specific needs. Once prescribed, the FIASP Pen can typically be acquired through pharmacies or online medical suppliers. When purchasing online, it is advisable to select reputable platforms that guarantee product authenticity. Many pharmacies also offer convenience features, such as home delivery and refill reminders, thus enhancing the overall user experience. Established drug suppliers often provide satisfaction guarantees or return policies, ensuring that users feel secure in their purchase.
Summary of results
In summary, FIASP Pen 100 IU by Novo Nordisk offers athletes an effective tool for managing blood glucose levels, significantly influencing athletic performance. Its rapid-action formulation allows for immediate energy access, crucial for intense physical activities. However, monitoring for side effects and ensuring personalized healthcare advice are paramount for maximized benefits and safety. The purchasing process is relatively accessible, particularly when complemented by professional guidance. Overall, the integration of FIASP can support not only improved glucose management but also enhanced athletic performance, making it a valuable asset in sports pharmacology.
Additional information
| Active substance | Insulin Aspart |
|---|---|
| Water Retention | Can cause modest water retention |
| Hepatotoxicity | No hepatotoxic effects known |
| Lab Test | Blood insulin levels, C-peptide test |
| Also known as | Exogenous insulin |
| Blood pressure | Can indirectly affect blood pressure by altering blood glucose levels |
| Trade name | Humulin, Novolin, Lantus, among others |
| Storage conditions | Must be kept refrigerated (2-8 degrees Celsius), avoid freezing |
| Chemical name | Insulin |
| Formula | C257H383N65O77S6 (for human insulin) |
| Substance class | Hormone, peptide |
| Main action | Lowers blood glucose levels |
| Half-life | Varies by type (Rapid-acting: 2-4 hours, Short-acting: 3-6 hours, Intermediate-acting: 12-18 hours, Long-acting: 20-24 hours) |
| Dosage (medical) | Depends on the patient's insulin sensitivity, carbohydrate intake, and blood glucose level, typically ranges from 0.5 to 1 unit/kg per day |
| Dosage (sports) | Not recommended for non-medical use |
| Effects | Decreases blood glucose, increases cellular glucose uptake, promotes glycogen synthesis |
| Side effects | Hypoglycemia, weight gain, insulin resistance, allergic reactions |
| Use in sports | Misused for anabolic purposes |
| Active ingredient, IU | 100 |
| Release form | Pen |
| Manufacturer | Novo Nordisk |
| Packing | Pen |




Reviews
There are no reviews yet.